Cargando…
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization
Glioblastoma (GBM) is a lethal brain cancer known for its potent immunosuppressive effects. Loss of Methylthioadenosine Phosphorylase (MTAP) expression, via gene deletion or epigenetic silencing, is one of the most common alterations in GBM. Here we show that MTAP loss in GBM cells is correlated wit...
Autores principales: | Hansen, Landon J., Yang, Rui, Roso, Kristen, Wang, Wenzhe, Chen, Lee, Yang, Qing, Pirozzi, Christopher J., He, Yiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907307/ https://www.ncbi.nlm.nih.gov/pubmed/35264604 http://dx.doi.org/10.1038/s41598-022-07697-0 |
Ejemplares similares
-
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
por: Engstrom, Lars D., et al.
Publicado: (2023) -
The Role of Myeloid Cells in GBM Immunosuppression
por: Lin, Ya-Jui, et al.
Publicado: (2022) -
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells
por: Singh, Simranjit X., et al.
Publicado: (2022) -
MTAP: The Motif Tool Assessment Platform
por: Quest, Daniel, et al.
Publicado: (2008) -
Deletion of Dinucleotide Repeat (Δ14 Allele) in the Methylthioadenosine Phosphorylase (MTAP) Promoter and the Allelotype of MTAP Promoter in the Japanese Population
por: Kadariya, Yuwaraj, et al.
Publicado: (2002)